Most of what is known about spermidine comes from cell and animal research, but a small number of randomized, placebo-controlled human trials have now been published, and they focus almost entirely on one outcome: memory in older adults with subjective cognitive decline.
This article is informational only and is not medical advice. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease.
The Pilot Trial (2018)
The first human trial was a three-month, randomized, double-blind, placebo-controlled Phase IIa pilot study in 30 participants aged 60 to 80 with subjective cognitive decline [1]. Participants took a spermidine-rich plant extract supplement, and the researchers reported a positive association between nutritional spermidine and memory performance, with the authors hypothesizing the effect might be mediated by neuromodulatory action in memory-related brain circuits.
The Safety Trial
Before scaling up, researchers published a dedicated safety and tolerability study covering both a 28-day mouse toxicity study and the human pilot cohort [2]. No differences were observed between spermidine and placebo groups in vital signs, weight, or standard clinical chemistry and hematology safety markers, and compliance exceeded 85%, supporting the intervention as well tolerated at the dose tested.
SmartAge: The Larger 12-Month Trial
Building on the pilot data, researchers designed and ran the SmartAge trial, a monocentric, randomized, double-masked, placebo-controlled Phase IIb study [3]. One hundred cognitively normal older adults with subjective cognitive decline were randomized 1:1 to 12 months of a spermidine-rich wheat germ extract supplement (0.9 mg spermidine/day) or placebo [4]. Eighty-nine participants (89%) completed the full year, and the primary outcome was change in memory performance measured by the Mnemonic Similarity Task, a validated test of pattern separation memory that is sensitive to early hippocampal changes.
Frequently Asked Questions
Has a large trial proven spermidine improves memory?
The SmartAge trial is the most rigorous human trial to date, a 12-month, 100-person, placebo-controlled RCT [4], but it studied a specific population (older adults with subjective cognitive decline, not the general population) and a specific dose (0.9 mg/day from wheat germ extract). It is meaningful evidence, not proof that spermidine benefits memory across all ages and doses.
What dose has been used in human trials?
Published human trials have used doses in the 0.9 to 1.2 mg/day range from spermidine-rich plant extract supplements [2][3], notably lower than the amounts found in some commercial wheat-germ-extract products marketed at 10 mg or more per serving. Higher doses have not been directly compared to this dose in controlled trials for cognitive outcomes.
Were the trials well tolerated?
Yes. The published safety data found no meaningful differences between spermidine and placebo groups in vital signs, weight, or standard blood chemistry, with compliance rates above 85% over three months [2]. This supports tolerability at the doses studied but does not establish long-term safety beyond the trial durations reported.
Recommended Spermidine Supplements
For readers deciding between specific products, two commonly available options are ProHealth Pure Spermidine 1 mg | 180 Capsules and Enhanced Absorption Pure Spermidine Supplement. As with any supplement, look for third-party testing and a clearly labeled spermidine or wheat germ extract content per serving before purchasing.
References
- Wirth M et al. The effect of spermidine on memory performance in older adults at risk for dementia: a randomized controlled trial. Cortex (2018). PMID 30388439
- Schwarz C et al. Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline. Aging (Albany NY) (2018). PMID 29315079
- Wirth M et al. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)-study protocol. Alzheimer’s Research & Therapy (2019). PMID 31039826
- Schwarz C et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Network Open (2022). PMID 35616942
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
